Tipmefast, Inc. Subsidiary Lucent Inc. Expands Strategic Acquisitions
Tipmefast, Inc. (OTC: TMEF) announced that its subsidiary, Lucent Inc., is pursuing strategic acquisitions to expand in the AI and EV battery sectors. Lucent is in advanced legal negotiations for acquisitions through stock swaps or joint R&D programs. The company is targeting APIs and pre-training models to enhance AI computing and application ecosystems, focusing on areas such as:
- Precision Medicine
- Drug Discovery
- Genomics
- Medical Imaging
- Bioinformatics
- IVF
These acquisitions aim to enhance Lucent's technology portfolio and position it at the forefront of innovation in biotech and EV sectors. The company's commitment to sustainable practices aligns with UN Sustainable Development Goals.
Tipmefast, Inc. (OTC: TMEF) ha annunciato che la sua sussidiaria, Lucent Inc., sta perseguendo acquisizioni strategiche per espandersi nei settori delle AI e delle batterie per veicoli elettrici. Lucent è in trattative legali avanzate per acquisizioni tramite operazioni di scambio azionario o programmi di ricerca e sviluppo congiunti. L'azienda punta a API e modelli di pre-addestramento per migliorare il calcolo AI e gli ecosistemi applicativi, concentrandosi su aree come:
- Medicina di precisione
- Scoperta di farmaci
- Genomica
- Imaging medico
- Bioinformatica
- IVF
Queste acquisizioni mirano a migliorare il portafoglio tecnologico di Lucent e a posizionarlo all'avanguardia nell'innovazione nei settori biotech e dei veicoli elettrici. L'impegno dell'azienda verso pratiche sostenibili è in linea con gli Obiettivi di Sviluppo Sostenibile delle Nazioni Unite.
Tipmefast, Inc. (OTC: TMEF) anunció que su subsidiaria, Lucent Inc., está buscando adquisiciones estratégicas para expandirse en los sectores de AI y baterías para vehículos eléctricos. Lucent se encuentra en negociaciones legales avanzadas para adquisiciones a través de intercambios de acciones o programas de I+D conjuntos. La empresa tiene como objetivo APIs y modelos de pre-entrenamiento para mejorar la computación y los ecosistemas de aplicaciones de AI, enfocándose en áreas como:
- Medicina de precisión
- Descubrimiento de fármacos
- Genómica
- Imágenes médicas
- Bioinformática
- FIV
Estas adquisiciones buscan mejorar el portafolio tecnológico de Lucent y posicionarlo a la vanguardia de la innovación en los sectores biotecnológico y de vehículos eléctricos. El compromiso de la empresa con prácticas sostenibles se alinea con los Objetivos de Desarrollo Sostenible de la ONU.
Tipmefast, Inc. (OTC: TMEF)는 자회사인 Lucent Inc.가 AI 및 전기차 배터리 분야에서 확장을 위해 전략적 인수를 추진하고 있다고 발표했습니다. Lucent는 주식 교환 또는 공동 연구 개발 프로그램을 통해 인수에 대한 고급 법률 협상 중에 있습니다. 이 회사는 AI 컴퓨팅 및 애플리케이션 생태계를 향상시키기 위해 API 및 사전 훈련 모델을 목표로 하고 있으며, 다음과 같은 분야에 집중하고 있습니다:
- 정밀 의학
- 약물 발견
- 유전체학
- 의료 영상
- 생명정보학
- IVF
이러한 인수는 Lucent의 기술 포트폴리오를 개선하고 생명공학 및 전기차 분야에서 혁신의 최전선에 위치하도록 하는 것을 목표로 하고 있습니다. 회사의 지속 가능한 관행에 대한 헌신은 유엔의 지속 가능한 개발 목표와 일치합니다.
Tipmefast, Inc. (OTC: TMEF) a annoncé que sa filiale, Lucent Inc., poursuit des acquisitions stratégiques pour se développer dans les secteurs de l'IA et des batteries pour véhicules électriques. Lucent est en pourparlers juridiques avancés pour des acquisitions via des échanges d'actions ou des programmes de R&D conjoints. L'entreprise vise à améliorer le calcul et les écosystèmes d'application AI à travers APIs et modèles de pré-formation, en se concentrant sur des domaines tels que :
- Médecine de précision
- Découverte de médicaments
- Génomique
- Imagerie médicale
- Bio-informatique
- FIV
Ces acquisitions visent à renforcer le portefeuille technologique de Lucent et à placer l'entreprise à la pointe de l'innovation dans les secteurs biotechnologique et des véhicules électriques. L'engagement de l'entreprise envers des pratiques durables est en ligne avec les Objectifs de Développement Durable des Nations Unies.
Tipmefast, Inc. (OTC: TMEF) hat angekündigt, dass ihre Tochtergesellschaft, Lucent Inc., strategische Übernahmen anstrebt, um sich in den Bereichen KI und Batterien für Elektrofahrzeuge zu erweitern. Lucent befindet sich in fortgeschrittenen rechtlichen Verhandlungen über Übernahmen, die durch Aktienwechsel oder gemeinsame F&E-Programme erfolgen sollen. Das Unternehmen zielt auf APIs und Vortrainingsmodelle ab, um das KI-Computing und die Anwendungsökosysteme zu verbessern, mit Fokus auf folgende Bereiche:
- Präzisionsmedizin
- Arzneimittelentdeckung
- Genomik
- Medizinische Bildgebung
- Bioinformatik
- IVF
Diese Übernahmen sollen das Technologieportfolio von Lucent verbessern und das Unternehmen an die Spitze der Innovation in den Biotech- und EV-Sektoren bringen. Das Engagement des Unternehmens für nachhaltige Praktiken steht im Einklang mit den UN-Zielen für nachhaltige Entwicklung.
- Lucent Inc. is pursuing strategic acquisitions in AI and EV battery sectors
- Advanced legal negotiations for acquisitions through stock swaps or joint R&D programs
- Focus on enhancing AI computing and application ecosystems in various healthcare fields
- Potential to strengthen Lucent's technology portfolio and market position
- Alignment with UN Sustainable Development Goals
- None.
SANTA ANA, CA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Tipmefast, Inc. (OTC: TMEF) today announced that Lucent, Inc., (Lucent or the “Company”), its wholly owned subsidiary, is pursuing strategic acquisitions to expand its presence in the AI and EV battery sectors. Lucent, headquartered in Irvine, CA, with offices in Taipei, Taiwan, is in advanced legal negotiations with key partners for acquisitions through stock swaps or joint R&D programs.
Lucent's acquisition focus includes:
APIs and Pre-Training Models for AI Applications: Lucent targets APIs and pre-training models to enhance AI computing and application ecosystems. Key areas include:
- Precision Medicine: Using AI to predict patient responses to treatments for personalized medicine.
- Drug Discovery: AI-driven analysis of large datasets to identify drug candidates and optimize design.
- Genomics: Machine learning to process genomic data for identifying disease markers and genetic risks.
- Medical Imaging: AI analysis of medical images for early disease detection.
- Bioinformatics: Integrating AI models to advance biological research and biotechnology development.
- IVF: AI to improve the success rate of in vitro fertilization.
Lucent is excited about the strategic opportunities these acquisitions present for the Company. By expanding its capabilities in AI and leveraging advanced pre-training models, Lucent will enhance its technology portfolio and be well-positioned at the forefront of innovation in the biotech and EV sectors. Lucent’s commitment to sustainable practices and aligning with the UN’s Sustainable Development Goals underscores its dedication to creating long-term value for shareholders and positively impacting the global community.
Further information on Lucent can be found at https://www.lucentlabs.ai
About Lucent Inc.:
Lucent’s mission is to revolutionize the AI datacenter and cloud computing industry by AI applications platform and harnessing the power of clean energy. With offices in Irvine, CA and Taipei, Taiwan, Lucent is committed to providing sustainable, reliable & high-performance solutions that empower businesses and public sectors to thrive in a digital world. Through collaboration & partnership with governments, businesses and communities, and unwavering dedication to environmental responsibility, Lucent strives to create a brighter, cleaner future for all.
Forward Looking Statements Disclaimer
Certain information set forth in this press release contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company’s current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.
These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.
Although forward-looking statements contained in this press release are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com
FAQ
What strategic acquisitions is Lucent Inc., a subsidiary of Tipmefast (TMEF), pursuing?
How is Lucent Inc. (TMEF) planning to execute these acquisitions?
What are the potential benefits of these acquisitions for Lucent Inc. (TMEF)?
How does Lucent Inc.'s (TMEF) acquisition strategy align with sustainability goals?
